Trabectedin improves patients with drug resistant metastatic leiomyosarcoma #SGOmtg

Martee L. Hensley, MD of Memorial Sloan Kettering discusses trabectedin improves patients with drug resistant metastatic leiomyosarcoma at SGO 2016.